Yang Zhao,1 Peter Sun,2 Mark Bernauer31Eli Lilly and Company, 2Kailo Research Group, 3OptumInsight, Indianapolis, IN, USABackground: The purpose of this study was to examine the main reasons for inpatient or outpatient visits after initiating duloxetine ...
Zhao Y, Sun P, Bernauer M
doaj
Comparative effectiveness of amitriptyline <i>vs</i> duloxetine in the treatment of chronic low back pain: An observational study. [PDF]
Sardar N +3 more
europepmc +1 more source
Advancing chronic low back pain management: Insights from amitriptyline and duloxetine comparison. [PDF]
Rath S.
europepmc +1 more source
Pregabalin and duloxetine combination for painful diabetic neuropathy: a systematic review and meta-analysis. [PDF]
Shi Y, Chen Y, Zhao H.
europepmc +1 more source
Clinical outcomes and safety of duloxetine and tolterodine combination in the treatment of mixed-type urinary incontinence: A single-arm retrospective study. [PDF]
Polat H +8 more
europepmc +1 more source
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain [PDF]
D\u27Souza, Deborah N +6 more
core +2 more sources
Dose-Concentration Relationship and Clinical Outcomes of Duloxetine in Generalized Anxiety Disorder. [PDF]
Baykan O +3 more
europepmc +1 more source
Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain. [PDF]
Campbell S +11 more
europepmc +1 more source
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients [PDF]
Hiromichi Mizuno +5 more
core +1 more source
Evaluation of the Efficacy and Safety of the Addition of Lacosamide to Duloxetine in the Treatment of Taxane-induced Peripheral Neuropathy: A Randomized Double-Blind Placebo-Controlled Trial. [PDF]
Moghimi M +7 more
europepmc +1 more source

